GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Zynex Inc (NAS:ZYXI) » Definitions » Cyclically Adjusted PB Ratio

Zynex (ZYXI) Cyclically Adjusted PB Ratio : 14.85 (As of May. 16, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Zynex Cyclically Adjusted PB Ratio?

As of today (2024-05-16), Zynex's current share price is $10.99. Zynex's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $0.74. Zynex's Cyclically Adjusted PB Ratio for today is 14.85.

The historical rank and industry rank for Zynex's Cyclically Adjusted PB Ratio or its related term are showing as below:

ZYXI' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.57   Med: 15.83   Max: 136.75
Current: 14.91

During the past years, Zynex's highest Cyclically Adjusted PB Ratio was 136.75. The lowest was 0.57. And the median was 15.83.

ZYXI's Cyclically Adjusted PB Ratio is ranked worse than
95.31% of 64 companies
in the Medical Distribution industry
Industry Median: 1.37 vs ZYXI: 14.91

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Zynex's adjusted book value per share data for the three months ended in Mar. 2024 was $1.037. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.74 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Zynex Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Zynex's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zynex Cyclically Adjusted PB Ratio Chart

Zynex Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 42.36 48.78 22.62 24.59 15.21

Zynex Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.73 14.79 11.63 15.21 16.75

Competitive Comparison of Zynex's Cyclically Adjusted PB Ratio

For the Medical Distribution subindustry, Zynex's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zynex's Cyclically Adjusted PB Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Zynex's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Zynex's Cyclically Adjusted PB Ratio falls into.



Zynex Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Zynex's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=10.99/0.74
=14.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zynex's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Zynex's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.037/131.7762*131.7762
=1.037

Current CPI (Mar. 2024) = 131.7762.

Zynex Quarterly Data

Book Value per Share CPI Adj_Book
201406 -0.060 100.560 -0.079
201409 -0.051 100.428 -0.067
201412 -0.035 99.070 -0.047
201503 -0.061 99.621 -0.081
201506 -0.074 100.684 -0.097
201509 -0.083 100.392 -0.109
201512 -0.116 99.792 -0.153
201603 -0.124 100.470 -0.163
201606 -0.130 101.688 -0.168
201609 -0.114 101.861 -0.147
201612 -0.108 101.863 -0.140
201703 -0.087 102.862 -0.111
201706 -0.044 103.349 -0.056
201709 0.045 104.136 0.057
201712 0.138 104.011 0.175
201803 0.148 105.290 0.185
201806 0.212 106.317 0.263
201809 0.259 106.507 0.320
201812 0.264 105.998 0.328
201903 0.330 107.251 0.405
201906 0.397 108.070 0.484
201909 0.461 108.329 0.561
201912 0.547 108.420 0.665
202003 0.641 108.902 0.776
202006 0.736 108.767 0.892
202009 1.421 109.815 1.705
202012 1.486 109.897 1.782
202103 1.465 111.754 1.727
202106 1.498 114.631 1.722
202109 1.657 115.734 1.887
202112 1.860 117.630 2.084
202203 1.885 121.301 2.048
202206 1.797 125.017 1.894
202209 1.740 125.227 1.831
202212 1.802 125.222 1.896
202303 1.760 127.348 1.821
202306 1.729 128.729 1.770
202309 1.712 129.860 1.737
202312 1.401 129.419 1.427
202403 1.037 131.776 1.037

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Zynex  (NAS:ZYXI) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Zynex Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Zynex's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Zynex (ZYXI) Business Description

Industry
Traded in Other Exchanges
N/A
Address
9555 Maroon Circle, Englewood, CO, USA, 80112
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufacture, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. it also develops and markets medical devices for non-invasive cardiac monitoring, the products of which are under development. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave and others.
Executives
Daniel J Moorhead officer: Chief Financial Officer 9777 PYRAMID CT, STE 100, ENGLEWOOD CO 80112
Anna Lucsok officer: See Remarks 9555 MAROON CIRCLE, ENGLEWOOD CO 80112
Thomas Sandgaard director, 10 percent owner, officer: President, CEO and Chairman 10506 KALAHARI CT., LONE TREE CO 80124
Neil Friery officer: See Remarks C/O ZYNEX, INC. 9555 MAROON CIRCLE, ENGLEWOOD CO 80112
Joshua R. Disbrow director AMPIO PHARMACEUTICALS, INC., 5445 DTC PARKWAY, SUITE 925, GREENWOOD VILLAGE CO 80111
Barry D Michaels director 6275 NANCY RIDGE DRIVE, SUITE 110, SAN DIEGO CA 92121
Michael D Cress director 3409 ESPERANZA CROSSING SUITE 7110, AUSTIN TX 78758
Sandgaard Holdings Llc 10 percent owner 9555 MAROON CIRCLE, ENGLEWOOD CO 80112
Giuseppe Papandrea officer: Chief Operating Officer C/O ZYNEX, INC. 9555 MAROON CIRCLE, ENGLEWOOD CO 80112